Description
Phase
Phase 3 - a treatment has shown activity against a particular disease, where it is either added to existing treatment or compared to the standard treatment.Inclusion and Exclusion Criteria
Please contact the trial administrator to learn more about the eligibility criteria for this trial. Please use the contact form on the right side.
Sites
-
California
- UCLA CARE Center CRS, Los Angeles, California, 90035
- Harbor-UCLA CRS, Torrance, California, 90502
- UCSD Antiviral Research Center CRS, San Diego, California, 92103
- Ucsf Hiv/Aids Crs, San Francisco, California, 94110
-
Colorado
- Denver Public Health CRS, Denver, Colorado, 80204
- University of Colorado Hospital CRS, Aurora, Colorado, 80045
-
Texas
- Trinity Health and Wellness Center CRS, Dallas, Texas, 75208
- Houston AIDS Research Team CRS, Houston, Texas, 77030
-
Illinois
- Rush University CRS, Chicago, Illinois, 60612
- Northwestern University CRS, Chicago, Illinois, 60611
-
Tennessee
- Vanderbilt Therapeutics (VT) CRS, Nashville, Tennessee, 37204
-
Alabama
- Alabama CRS, Birmingham, Alabama, 35294
-
Ohio
- Cincinnati Clinical Research Site, Cincinnati, Ohio, 45219
- Cincinnati CRS, Cincinnati, Ohio, 45219
Powered by
SC CTSI